Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
02/09/2012 | US20120034230 Cna-B DOMAIN ANTIGENS IN VACCINES AGAINST GRAM POSITIVE BACTERIA |
02/09/2012 | US20120034229 Monoclonal antibodies directed against lg4-5 domain of alpha3 chain of human laminin-5 |
02/09/2012 | US20120034228 CROSS-SPECIES-SPECIFIC PSCAxCD3, CD19xCD3, C-METxCD3, ENDOSIALINxCD3, EPCAMxCD3, IGF-1RxCD3 OR FAPALPHAxCD3 BISPECIFIC SINGLE CHAIN ANTIBODY |
02/09/2012 | US20120034227 Monoclonal antibody therapy for pancreas cancer |
02/09/2012 | US20120034221 T-Cell Receptor Antibodies And Methods of Use Thereof |
02/09/2012 | US20120034220 Mucin Fusion Polypeptide Vaccines, Compositions And Methods Of Use Thereof |
02/09/2012 | US20120034219 Uses of il-23 agonists and antagonists; related reagents |
02/09/2012 | US20120034215 Anti-mst1r antibodies and uses thereof |
02/09/2012 | US20120034213 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
02/09/2012 | US20120034212 Human Anti-IL-6 Antibodies With Extended In Vivo Half-Life And Their Use In Treatment Of Oncology, Autoimmune Diseases And Inflammatory Diseases |
02/09/2012 | US20120034207 Production of her receptor antibodies in plant |
02/09/2012 | US20120034206 Breast cancer eradication program |
02/09/2012 | US20120034196 Gene encoding a multidrug resistance human p-glycoprotein homologue on chromosome 7p15-21 and uses thereof (frank) |
02/09/2012 | US20120034188 Akt Nucleic Acids, Polypeptides, and Uses Thereof |
02/09/2012 | US20120034185 Anti-cd20 antibodies and fusion proteins therof and methods of use |
02/09/2012 | US20120034168 Isolated Monoclonal Antibody or Fragment Thereof Binding Prostate Specific Membrane Antigen, Conjugates and Uses Thereof |
02/09/2012 | US20120034166 Amyloid beta(1-42) oligomers, derivatives thereof and antibodies thereto, methods of preparation thereof and use thereof |
02/09/2012 | US20120034161 Pretargeting kit, method and agents used therein |
02/09/2012 | US20120034160 Dual variable domain immunoglobulins and uses thereof |
02/09/2012 | US20120034159 Antibodies that bind both bcma and taci |
02/09/2012 | DE102010039015A1 Linkerpeptid und seine Verwendung in Fusionsproteinen Linker peptide and its use in fusion proteins |
02/09/2012 | CA2815154A1 Use of her3 binding agents in prostate treatment |
02/09/2012 | CA2807529A1 Combination pharmaceutical composition and methods of treating and preventing the infectious diseases |
02/09/2012 | CA2807440A1 Methods and compounds for the diagnosis and treatment of cancer |
02/09/2012 | CA2807282A1 Mice that make binding proteins comprising vl domains |
02/09/2012 | CA2807127A1 Covalent diabodies and uses thereof |
02/09/2012 | CA2807014A1 Dual variable domain immunoglobulins and uses thereof |
02/09/2012 | CA2806855A1 Chronic lymphocytic leukemia (cll) biomarkers |
02/09/2012 | CA2806029A1 Antibodies relating to pivka-ii and uses thereof |
02/09/2012 | CA2805685A1 Concentrated human immunoglobulin composition |
02/09/2012 | CA2805564A1 Anti-mhc antibody anti-viral cytokine fusion protein |
02/09/2012 | CA2804967A1 Combination pharmaceutical composition and methods of treating diseases or conditions associated with neurodegenerative diseases |
02/08/2012 | EP2415876A1 Highly sensitive detection method for highly virulent oral cavity bacteria |
02/08/2012 | EP2415868A1 Method and kit for evaluation of predisposition to development of obesity, anti-obesity agent and method for screening thereof, non-human animal, adipose tissue, adipocyte, method for production of transgenic mouse, antigen, and antibody |
02/08/2012 | EP2415785A1 Novel antibodies inhibiting C-Met dimerization, and uses thereof |
02/08/2012 | EP2415784A1 Novel antibodies inhibiting C-Met dimerization, and uses thereof |
02/08/2012 | EP2415781A1 Antigenic determinants recognized by anti-human death receptor dr5 monoclonal antibody ad5-10, derivatives and uses thereof |
02/08/2012 | EP2414841A2 Diagnosis of gluten-induced autoimmune diseases |
02/08/2012 | EP2414840A2 Assys for bacterial detection and identification |
02/08/2012 | EP2414399A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use |
02/08/2012 | EP2414398A2 Antibodies against human tweak and uses thereof |
02/08/2012 | EP2414397A1 Adenylyl cyclase-associated protein (cap1) and uses thereof as a target for immuno-modulation |
02/08/2012 | EP2414396A2 Preparation of isolated agonist anti-edar monoclonal antibodies |
02/08/2012 | EP2414395A1 Anti-fcrh5 antibodies and immunoconjugates and methods of use |
02/08/2012 | EP2414394A2 Therapeutic agents for the treatment of diseases associated with undesired cell proliferation |
02/08/2012 | EP2414393A1 Anti-il-23 immunoglobulins |
02/08/2012 | EP2414392A2 Human monoclonal antibody that specifically binds to vcam-1 and a composition for treating an inflammatory disease or a cancer comprising the same |
02/08/2012 | EP2414391A1 Multispecific antibodies comprising full length antibodies and single chain fab fragments |
02/08/2012 | EP2414383A1 C6orf167 peptides and vaccines containing the same |
02/08/2012 | EP2414043A1 Bmp-alk3 antagonists and uses for promoting bone growth |
02/08/2012 | EP2413969A2 Fusion proteins comprising canine fc portions |
02/08/2012 | EP2413968A1 Semaphorin 3c (sema3c) inhibitor therapeutics, methods, and uses |
02/08/2012 | EP2413967A1 Treatment of insulin-resistant disorders |
02/08/2012 | EP2413965A1 Treatment of cancer with a humanized anti-egfr igg1 antibody and irinotecan |
02/08/2012 | EP2413957A2 Pharmaceutical composition |
02/08/2012 | EP2413689A2 Mouse models |
02/08/2012 | EP2102235B1 Treatment of cachexia |
02/08/2012 | EP1711531B1 Neutralizing anti tlr4/md-2 antibodies and methods of use thereof |
02/08/2012 | EP1620468B1 Fusion polypeptide suitable as a cytotoxin |
02/08/2012 | EP1572937B1 Motif-grafted hybrid polypeptides and uses thereof |
02/08/2012 | CN102348722A Human cgrp receptor binding proteins |
02/08/2012 | CN102346191A Muscovy duck gosling plague latex particle agglutination reagent and preparation method thereof |
02/08/2012 | CN102344926A Simple and convenient chemical industrial technology for prokaryotic expression and purification of humanized anti-vascular endothelial growth factor (Anti-VEGF) monoclonal recombinant antibody |
02/08/2012 | CN102344493A Antibodies combined to PSCA proteins for cancer diagnosis |
02/08/2012 | CN102344492A Method for targeting retrovirus by bidirectional specific ligand |
02/08/2012 | CN102344491A Interferon alpha antibodies and their uses |
02/08/2012 | CN102344490A Anti-mouse Stk40 polyclonal antibody and preparation thereof |
02/08/2012 | CN101914499B Anti-waterfowl parvovirus VP3 protein monoclonal antibody |
02/08/2012 | CN101875696B 一种抗体及其制备方法与应用 An antibody preparation method and application |
02/08/2012 | CN101374944B 用于获得永生化抗体分泌细胞的方法 Immortalized antibody-secreting cells obtained method for |
02/08/2012 | CN101217978B 通过给予神经生长因子拮抗剂及其组合物来治疗骨关节炎疼痛的方法 By administering an antagonist of nerve growth factor and combinations thereof to treat osteoarthritis pain |
02/07/2012 | US8110671 Isolated human chromosome 14 fragment encoding immunoglobulin genes |
02/07/2012 | US8110665 Pharmaceutical composition comprising an immunoglobulin FC region as a carrier |
02/07/2012 | US8110664 Binding partners for the thyrotropin receptor and uses thereof |
02/07/2012 | US8110663 Monoclonal antibodies for cartillage oligomeric matrix protein |
02/07/2012 | US8110662 Culture product; hybridization; antibody that binds to purified polypeptide |
02/07/2012 | US8110661 Anti-IP-10 antibodies and methods of use thereof |
02/07/2012 | US8110657 Polypeptides and polynucleotides for enhancing immune reactivity to HER-2 protein |
02/07/2012 | US8110654 T cell epitope peptides of ovarian cancer anti-idiotypic antibody 6B11 and use thereof |
02/07/2012 | US8110550 HDAC inhibitors and hormone targeted drugs for the treatment of cancer |
02/07/2012 | US8110391 Degradation and detection of TSE infectivity |
02/07/2012 | US8110378 Nucleic acids encoding DCRS5 |
02/07/2012 | US8110370 IBC-1 (Invasive Breast Cancer-1), a putative oncogene amplified in breast cancer |
02/07/2012 | US8110367 Methods for diagnosing renal disorders |
02/07/2012 | US8110203 Adjuvant comprising non-toxic cross-linked muramyl dipeptide (MDP) microparticles derived from Propionibacterium acnes |
02/07/2012 | US8110195 Antibody composition exhibiting cellular cytotoxicity due to glycosylation and containing ganglioside GM2 binding antibody |
02/07/2012 | US8110192 Human immunodeficiency virus type 1 (HIV-1)-neutralizing human single-chain antibodies with improved breadth and potency |
02/07/2012 | US8110191 Anti-IL-17 antibodies |
02/07/2012 | US8110189 Using monoclonal antibody specific to biliary glycoprotein as tool in treatment and prevention of cell proliferative, autoimmune, immunodeficiency and transplant rejection disorders |
02/07/2012 | US8110188 Compositions for prevention and treatment of infections caused by coccidia in chickens |
02/07/2012 | US8110187 Purification and characterization of cytotoxic lymphocyte maturation factor and monoclonal antibodies thereto |
02/07/2012 | CA2509068C Antibody ("11c7") anti nogo a and its pharmaceutical use |
02/07/2012 | CA2497418C A method for diagnosing cancer by detecting gpc3 |
02/07/2012 | CA2386463C April receptor (bcma) and uses thereof |
02/07/2012 | CA2348971C Novel serine proteases bssp4 |
02/07/2012 | CA2333147C Cancer treatment methods using antibodies to aminophospholipids |
02/07/2012 | CA2328989C Serpentine transmembrane antigens expressed in human cancers and uses thereof |
02/07/2012 | CA2301964C Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
02/07/2012 | CA2273196C Isolated mammalian monocyte cell genes; related reagents |
02/07/2012 | CA2264484C Human plasma hyaluronidase |